Viswanathan Natarajan Selected Research

Enzymes

9/2021	My Journey in Academia as a Lipid Biochemist.
6/2020	Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.
1/2020	Mitochondrial 8-oxoguanine DNA glycosylase mitigates alveolar epithelial cell PINK1 deficiency, mitochondrial DNA damage, apoptosis, and lung fibrosis.
12/2016	Targeting sphingosine-1-phosphate signaling in lung diseases.
1/2016	Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium.
6/2014	The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.
7/2013	Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
10/2009	NOX enzymes and pulmonary disease.
3/2009	Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
5/2005	Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Viswanathan Natarajan Research Topics

Disease

29	Lung Injury 12/2022 - 04/2003
25	Inflammation (Inflammations) 01/2024 - 08/2002
20	Hyperoxia 01/2022 - 01/2003
17	Pneumonia (Pneumonitis) 03/2022 - 04/2009
16	Acute Lung Injury 01/2022 - 09/2005
13	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2021 - 08/2012
13	Fibrosis (Cirrhosis) 08/2020 - 01/2013
11	Infections 03/2021 - 07/2003
10	Asthma (Bronchial Asthma) 01/2024 - 04/2007
10	Neoplasms (Cancer) 12/2019 - 02/2003
8	Hypoxia (Hypoxemia) 11/2022 - 12/2010
8	Bronchopulmonary Dysplasia 01/2022 - 10/2013
8	Sepsis (Septicemia) 09/2021 - 04/2009
7	Lung Diseases (Lung Disease) 03/2020 - 11/2006
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2024 - 12/2003
6	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2008
6	Idiopathic Pulmonary Fibrosis 03/2020 - 04/2013
4	Pulmonary Arterial Hypertension 11/2022 - 10/2009
3	Critical Illness (Critically Ill) 06/2024 - 01/2013
3	Airway Remodeling 03/2024 - 01/2020
3	Pulmonary Hypertension 11/2022 - 11/2014
3	Vascular Remodeling 11/2022 - 12/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 09/2009
3	Pulmonary Edema 01/2022 - 12/2003
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2016
3	Ventilator-Induced Lung Injury 01/2022 - 12/2015
3	Pathologic Processes 01/2020 - 05/2009
3	Prostatic Neoplasms (Prostate Cancer) 06/2013 - 12/2010
3	Breast Neoplasms (Breast Cancer) 12/2010 - 10/2004
2	Retinoblastoma (Glioblastoma, Retinal) 08/2022 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 01/2022
2	COVID-19 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
2	Respiratory Hypersensitivity 01/2020 - 11/2008
2	Necrosis 01/2019 - 01/2015
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 09/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 04/2012

Drug/Important Bio-Agent (IBA)

26	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2024 - 08/2002
21	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2003
19	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2003
15	sphingosine kinaseIBA 01/2024 - 08/2010
15	SphingolipidsIBA 01/2022 - 08/2002
13	lysophosphatidic acidIBA 09/2021 - 03/2009
12	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2003
12	LipidsIBA 06/2020 - 05/2005
11	SphingosineIBA 01/2022 - 04/2009
11	CytokinesIBA 01/2022 - 09/2005
11	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2007
10	EnzymesIBA 09/2021 - 05/2005
10	Bleomycin (Blenoxane)FDA LinkGeneric 08/2020 - 04/2013
9	Phosphotransferases (Kinase)IBA 01/2022 - 01/2003
8	Tyrosine (L-Tyrosine)FDA Link 05/2015 - 04/2003
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2005
7	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 01/2003
6	AllergensIBA 01/2024 - 02/2006
6	Superoxides (Superoxide)IBA 11/2017 - 01/2003
5	CortactinIBA 01/2022 - 08/2007
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2006
5	Phosphates (Orthophosphate)IBA 09/2021 - 05/2009
5	Phospholipids (Phosphatides)FDA LinkGeneric 09/2021 - 05/2006
5	Sphingosine-1-Phosphate ReceptorsIBA 12/2019 - 10/2010
5	1-dodecylpyridoxal (PLD)IBA 01/2019 - 04/2003
5	CeramidesIBA 01/2018 - 05/2005
5	LyasesIBA 01/2017 - 10/2013
5	Lysophosphatidic Acid ReceptorsIBA 12/2013 - 11/2009
4	SmokeIBA 06/2024 - 01/2021
4	PF-543IBA 01/2024 - 01/2020
4	LipopolysaccharidesIBA 01/2022 - 05/2006
4	Extracellular Matrix ProteinsIBA 06/2020 - 12/2013
4	sphingosine 1-phosphate lyase (aldolase)IBA 01/2018 - 08/2011
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 06/2013
4	PaxillinIBA 12/2015 - 01/2008
3	LigandsIBA 12/2022 - 01/2021
3	Nicotinamide PhosphoribosyltransferaseIBA 01/2022 - 11/2005
3	Mitochondrial DNA (mtDNA)IBA 08/2020 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 08/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 05/2005
3	Phospholipase DIBA 01/2019 - 04/2003
3	Histones (Histone)IBA 01/2019 - 01/2012
3	NADP (NADPH)IBA 12/2017 - 01/2003
3	NADPH Oxidase 4IBA 11/2017 - 06/2011
3	Organophosphonates (Phosphonates)IBA 01/2016 - 07/2013
3	Particulate MatterIBA 04/2012 - 11/2008
2	GTP Phosphohydrolases (GTPases)IBA 12/2022 - 12/2009
2	Cardiolipins (Cardiolipin)IBA 03/2022 - 06/2014
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2005
2	Oxygen (Dioxygen)IBA 09/2021 - 01/2013
2	AsbestosIBA 08/2020 - 01/2020
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2020 - 01/2012
2	LysophospholipidsIBA 06/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 01/2015
2	Oxidants (Oxidizing Agents)IBA 01/2020 - 12/2005
2	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2019 - 02/2015
2	indium-bleomycinIBA 01/2019 - 04/2013
2	Protein Kinase CIBA 01/2019 - 03/2011

Therapy/Procedure

12	Therapeutics 01/2022 - 05/2005
7	Mechanical Ventilators (Ventilator) 01/2022 - 04/2009
4	Artificial Respiration (Mechanical Ventilation) 12/2022 - 07/2013